Stephanie Kershaw

Dr. Stephanie Kershaw


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2023 in JMIR Medical Education
Verified
Journal Article
Open access
SSSophia Spallek
Sophia Spallek
LBLouise Birrell
Louise Birrell
SKStephanie Kershaw
Stephanie Kershaw
EDEmma Krogh Devine
Emma Krogh Devine
LTLouise Thornton
Louise Thornton
Background: The use of generative artificial intelligence, more specifically large language models (LLMs), is proliferating, and as such, it is vital to consider both the value and potential harms of its use in medical education. Their efficiency in a variety of writing styles makes LLMs, such as ChatGPT, attractive for tailoring educational materials. However, this technology can feature biases and misinformation, which can be particularly harmful in medical education settings, such as mental health and substance use education. This viewpoint investigates if ChatGPT is sufficient for 2 common health education functions in the field of mental health and substance use: (1) answering users’ direct queries and (2) aiding in the development of quality consumer educational health materials. Objective: This viewpoint includes a case study to provide insight into the accessibility, biases, and quality of ChatGPT’s query responses and educational health materials. We aim to provide guidance for the general public and health educators wishing to utilize LLMs. Methods: We collected real world queries from 2 large-scale mental health and substance use portals and engineered a variety of prompts to use on GPT-4 Pro with the Bing BETA internet browsing plug-in. The outputs were evaluated with tools from the Sydney Health Literacy Lab to determine the accessibility, the adherence to Mindframe communication guidelines to identify biases, and author assessments on quality, including tailoring to audiences, duty of care disclaimers, and evidence-based internet references. Results: GPT-4’s outputs had good face validity, but upon detailed analysis were substandard in comparison to expert-developed materials. Without engineered prompting, the reading level, adherence to communication guidelines, and use of evidence-based websites were poor. Therefore, all outputs still required cautious human editing and oversight. Conclusions: GPT-4 is currently not reliable enough for direct-consumer queries, but educators and researchers can use it for creating educational materials with caution. Materials created with LLMs should disclose the use of generative artificial intelligence and be evaluated on their efficacy with the target audience.

1 January 2021 in International Journal of Drug Policy
Verified
Journal Article
Open access
HDHannah Deen
Hannah Deen
SKStephanie Kershaw
Stephanie Kershaw
NNNicola Newton
Nicola Newton
LSLexine Stapinski
Lexine Stapinski
LBLouise Birrell
Louise Birrell
CCCath Chapman
Cath Chapman
Crystal methamphetamine attracts an elevated level of negative attention in Australia and internationally, however there is a paucity of research into stigma and discrimination surrounding this drug. This study aimed to investigate and compare levels of public stigma, self-stigma and discrimination surrounding crystal methamphetamine use in a large sample of Australian residents. A cross-sectional online survey, open to all Australian residents aged 18 years and over, was conducted from November 2018 to March 2019 examining stigmatising attitudes towards people who use crystal methamphetamine. Respondents also reported any personal history of crystal methamphetamine use and experiences of discrimination. Multiple linear regression examined whether prior crystal methamphetamine use was associated with holding stigmatising attitudes. Covariates included in the analysis were presence of a family member or friend who uses crystal methamphetamine, knowledge about crystal methamphetamine, gender, age and region. A total of 2108 Australian participants completed the study (mean age = 36.3 years; 59% females; 27% had used crystal methamphetamine). Many participants reported being discriminated against because of their crystal methamphetamine use. Stigmatising attitudes were prevalent, particularly among those who hadn't used crystal methamphetamine (p<.001). Others more likely to endorse stigmatising attitudes included females (p=.004 vs. males), individuals with less knowledge about crystal methamphetamine (p<.001) and those living in regional (p<.001) and rural/remote locations (p<.001) compared to metropolitan areas. Stigma and discrimination surrounding crystal methamphetamine use was common in this sample of Australian residents, with public stigma more prevalent than self-stigma. This highlights a need for stigma reduction initiatives. Given higher levels of knowledge were associated with less stigmatising attitudes, public education campaigns providing accurate, evidence-based information about crystal methamphetamine along with guidelines and support for accurate media reporting, present promising approaches to stigma reduction. Exploration of other stigma reduction initiatives is also vital to ensuring people who use crystal methamphetamine feel supported in seeking help.

26 May 2024 in Health Promotion Journal of Australia
Verified
Journal Article
Open access
JDJennifer Debenham
Jennifer Debenham
LBLouise Birrell
Louise Birrell
NNNicola C. Newton
Nicola C. Newton
EDEmma K. Devine
Emma K. Devine
KCKatrina E. Champion
Katrina E. Champion
ESEmily Stockings
Emily Stockings
Issue Addressed: Substance use and mental illness remain critical issues for young Australians, however, engagement with evidence‐based health resources is challenging among this age group. This study aimed to develop engaging, useful digital health resources, underpinned by neuroscience principles, to build awareness of the harms of electronic cigarettes (e‐cigarettes) and concurrent alcohol and antidepressant use.Methods: A mixed‐methods approach was adopted to co‐design two evidence‐based videos resources. The resources were co‐designed with the Matilda Centre's Youth Advisory Board Centre's Youth Advisory Board through a series focus groups and individual feedback reviews. Young people residing in New South Wales were then invited to complete a survey to evaluate the usefulness, relatability and impact on perceived harms associated with each substance pre‐ and post‐viewing resources.Results: A total of 100 participants completed the survey (mean age = 21.5 years, SD = 2.77, 42% Female, 2% Non‐binary). The animated videos were well received, with the large majority (91% and 87% respectively) of participants rating them ‘excellent’ or ‘very good’. After viewing the videos, there was a significant increase in the perception of harm associated with e‐cigarette use, monthly (t(99) = 2.76, p = .003), weekly (t(99) = 4.82, p < .001) and daily (t(99) = 4.92, p < .001), and consuming alcohol whilst taking antidepressants both weekly (t(100) = 2.93, p = .004) and daily (t(100) = 3.13, p = .002).Conclusions: This study describes a successful co‐design process demonstrating how meaningful involvement of young people, alongside traditional research methods, can produce substance use prevention resources that are useful, engaging and increase knowledge of harms among young people.So What?: To achieve meaningful public health impact researchers, experts and digital creators can work together to co‐create substance use educational materials that are engaging, well‐liked, while imparting important health knowledge.

10 August 2021 in Journal of Medical Internet Research
Verified
Journal Article
Open access
SKStephanie Kershaw
Stephanie Kershaw
LBLouise Birrell
Louise Birrell
HDHannah Deen
Hannah Deen
NNNicola C Newton
Nicola C Newton
LSLexine Stapinski
Lexine Stapinski
CCCath Chapman
Cath Chapman
Background: The Cracks in the Ice (CITI) community toolkit was developed to provide evidence-based, up-to-date information and resources about crystal methamphetamine to Australians. Given the high rates of internet use in the community and the potential for misinformation, CITI has the potential to play an important role in improving knowledge and challenging misconceptions surrounding crystal methamphetamine. Objective: This study aims to determine (1) whether the CITI toolkit is achieving its aim of disseminating evidence-based information and resources to people who use crystal methamphetamine, their family and friends, health professionals, and the general community and (2) examine the association between the use of CITI and the knowledge and attitudes about crystal methamphetamine. Methods: A cross-sectional web-based survey, open to Australian residents (aged ≥18 years), was conducted from November 2018 to March 2019. People who had previously visited the website (referred to as “website visitors” in this study) and those who had not (“naïve”) were recruited. At baseline, knowledge, attitudes, and demographics were assessed. CITI website visitors then completed a series of site evaluation questions, including the System Usability Scale (SUS), and naïve participants were asked to undertake a guided site tour of a replicated version of the site before completing the evaluation questions and repeating knowledge and attitude scales. Results: Of a total 2108 participants, 564 (26.7%) reported lifetime use of crystal methamphetamine, 434 (20.6%) were family/friends, 288 (13.7%) were health professionals, and 822 (38.9%) were community members. The average SUS score was 73.49 (SD 13.30), indicating good site usability. Health professionals reported significantly higher SUS scores than community members (P=.02) and people who used crystal methamphetamine (P<.001). Website visitors had significantly higher baseline knowledge than naïve participants (P<.001). Among naïve participants, knowledge scores increased following exposure to the website (mean 15.2, SE 0.05) compared to baseline (mean 14.4, SE 0.05; P<.001). The largest shifts in knowledge were observed for items related to prevalence, legal issues, and the effects of the drug. Stigmatizing attitude scores among the naïve group were significantly lower following exposure to CITI (mean 41.97, SE 0.21) compared to baseline (mean 44.3, SE 0.21; P<.001). Conclusions: This study provides an innovative evaluation of a national eHealth resource. CITI is achieving its aim of disseminating evidence-based, nonstigmatizing, and useful information and resources about crystal methamphetamine to key end user groups and has received good usability scores across its target groups. Interaction with CITI led to immediate improvements in knowledge about crystal methamphetamine and a decrease in stigmatizing attitudes. CITI demonstrates the important role of digital information and support platforms for translating evidence into practice and improving knowledge and reducing stigma.

4 July 2024 in Drug and Alcohol Review
Verified
Journal Article
Open access
SKStephanie Kershaw
Stephanie Kershaw
MSMatthew Sunderland
Matthew Sunderland
AGAnna Grager
Anna Grager
LBLouise Birrell
Louise Birrell
HDHannah Deen
Hannah Deen
CCCath Chapman
Cath Chapman
Introduction: Barriers to help‐seeking for illicit drug use cross psychosocial (e.g., knowledge of where to seek help, attitudinal beliefs like being afraid of what people will think) and structural (e.g., service availability) domains. Along with people who use illicit drugs, it is important to consider the perspectives of other key groups who are often involved in the help‐seeking and recovery process. This study aimed to examine the perceived barriers to help‐seeking for people who use crystal methamphetamine (‘ice’) among key groups (people who use crystal methamphetamine, families and friends, health workers) as well as the general community.Methods: A cross‐sectional online survey open to all Australian residents (aged ≥18 years) was conducted November 2018–March 2019. Four key groups of interest were recruited to examine and compare perceived barriers to help‐seeking for crystal methamphetamine use.Results: Participants (n = 2108) included: people who use/have used crystal methamphetamine (n = 564, 39%), health workers (n = 288, 26.8%), affected family/friends (n = 434, 13.7%) and general community (n = 822, 20.6%). People who used crystal methamphetamine demonstrated increased odds of reporting attitudinal (OR 1.35; 1.02–1.80) or structural (OR 1.89; 1.09–3.27) barriers, or a previous negative help‐seeking experience (OR 2.27; 1.41–3.66) compared to knowledge barriers. Health workers demonstrated decreased odds of reporting attitudinal compared to knowledge barriers (OR 0.69; 0.50–0.95).Discussion and Conclusions: Perceived barriers to seeking help for crystal methamphetamine use differed among key groups involved in treatment and recovery. Acknowledging and addressing the mismatches between key groups, through targeted interventions may better support people to seek help for crystal methamphetamine use.

5 September 2025 in International Journal of Drug Policy
Verified
Journal Article
Open access
SKStephanie Kershaw
Stephanie Kershaw
JDJessica Deng
Jessica Deng
GBGeorgette Borel
Georgette Borel
Siobhan O'DeanSiobhan O'Dean
Siobhan O'Dean
JWJack Wilson
Jack Wilson
CCCath Chapman
Cath Chapman
Drug-related deaths are a significant and growing public health concern. In Australia, meth/amphetamine is the most common stimulant drug involved in unintentional drug-related deaths. People who use meth/amphetamine often experience stigma and are negatively portrayed in the media. Considering the influence of media on public attitudes, which in turn influences policy, this study aimed to examine the relationships between media representations of drug-related deaths and stigma towards the people who use drugs along with attitudes towards harm reduction policy. Nationally representative sample of Australians (N = 1490) participated in an online experimental study where they were randomised to one of eight simulated news stories depicting a drug-related death. Each news story varied by drug type (methamphetamine or alternative stimulant (MDMA, 'ecstasy')), age of the character depicted (younger or older), and gender of the character depicted (female or male). Stigma towards the character depicted and support for harm reduction was assessed. Data were analysed using MANOVA. Among the sample (average age = 48.5 years (SD 17.73); 54.7% female). Stigma was higher towards depictions of older people compared to younger people (p < .001) and those who had used methamphetamine compared to MDMA (p < .001). No significant main effects on support for harm reduction were found. Certain characteristics in news stories about drug-related deaths elicit higher stigma towards the depicted person. Thus, improving how the media report and frame drug-related deaths represents an important avenue to reduce stigma towards people who use drugs and in turn foster public support for evidence-based drug policies.